Risk factor
Limited trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products....
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Target Price
The average target price of AMBU-B.CO is 119 and suggests 35% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to in
Buy
Sell